Massive bleeding in polytrauma: how can we make progress?

Trauma is a major cause of death worldwide, with some 30% of deaths associated with hemorrhage. Rapid control of bleeding in such patients is thus an essential aspect of trauma care. Recombinant human factor VIIa is sometimes used off-label in massively bleeding patients and has been demonstrated in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Vincent, Jean-Louis, Dutton, Richard, Parr, Michael, Hauser, Carl
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2011
Konular:
Commentary
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3334747/
https://ncbi.nlm.nih.gov/pubmed/21996523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc10438
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller